Timeline

Voting rights breakdown

Declared beneficial owners · 4

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

• Frank-Jan van der Velden 141.4%
• Clemens van Blitterswijk 241.4%
• Joost de Bruijn 341.4%
• Yuan Huipin 441.4%

Notice details

Beneficial owner

Frank-Jan van der Velden 1

Date of transfer of equity securities: early 2017 Conditional Right to acquire new shares pursuant to a Combination Agreement entered with Kuros Biosciences AG on 18 December 2016: 1'365'000 shares of Kuros Biosciences Ltd to be acquired at closing of the Combination Agreement in early 2017 and 740'000 shares of Kuros Biosciences Ltd to be acquired on the achievement of certain product approval milestones. A) Incubation B.V., Bilthoven, controlled by (i) Dagomar B.V., Echteld, the Netherlands, a company controlled by Person 1 and (ii) Dr. C.A. van Blitterswijk Holding B.V., Ruigahuizen, the Netherlands, a company controlled by Person 2; (B) Aldabra B.V., Amersfoort, the Netherlands, a company controlled by Person 3 and (C) Person 4 shall acquire the shares.